Health & Biotech How Covax Australia’s post pandemic pivot is easing the aged care staffing crisis November 29, 2022 Special Report: The Australian workforce company emerged almost overnight to become a crucial part of the national response to the… ASX Health Stocks: Sonic snaps up stake in Microba, sending MAP share price 60pc higher November 29, 2022 ASX giant Sonic Healthcare (ASX: SHL) has bought a stake in small cap lister Microba Life Sciences (ASX:MAP). ASX Health Stocks: FDA greenlights Anteris study, Respiri selected in Arkansas November 28, 2022 Anteris says the FDA has conditionally approved the DurAVR Transcatheter Heart Valve (THV) System for investigational device exemption (IDE). Owners of dogs in PharmAust’s Phase 2 trial are very grateful with results November 28, 2022 Special Report: Owners of dogs participating in the MPL trial said they have seen an increase in the quality of life… Incannex appoints Eurofins to manufacture novel addiction treatments CannQuit-N and CannQuit-O November 25, 2022 Special Report: Incannex is teaming with Eurofins to help people with opioid and nicotine addiction disorders, by undertaking formulation development… ASX Health Stocks: Argenica steps up dose in Phase 1 trial; Medlab gets blessing from UK regulator November 25, 2022 Argenica Therapeutics (ASX:AGN) announced that the first subjects in the third cohort of its Phase 1 trial of ARG-007 have… ASX Health Stocks: Little Green Pharma ships new cannabis flowers from Denmark to Australia November 24, 2022 Cannabis play Little Green Pharma (ASX:LGP) rose 3% today after revealing the expansion of its flower portfolio. Weed Week: Oregon pardons cannabis convictions and bulk people light up on Turkey Day November 24, 2022 Oregon Governor pardons 45,000 people and dispensaries see a 50% increase in transactions before 'Danksgiving'. How out of favour Biotech has a PR problem and could learn from Dr Karl November 24, 2022 ASX health stocks have fallen out of favour in 2022 with a a rotation out of growth into value sectors… Planets align as Exopharm advances its technologies and experts report that exosomes may hold the key to mRNA therapeutics November 24, 2022 Special Report: With various studies identifying exosomes as a preferred drug-delivery option for some mRNA therapeutics, Exopharm is centre stage to… Next» « Previous